Viewing Study NCT06312020


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2025-12-26 @ 3:11 AM
Study NCT ID: NCT06312020
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-24
First Post: 2024-02-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module